Skip to main content

Tallinna Vesi’s third-quarter sales reached €18.2 million

The sales of AS Tallinna Vesi in the third quarter of 2025 were €18.2 million, increasing 10.8% compared to the same period last year. Revenue growth was most affected by a change in price due to the need for critical investments.  Aleksandr Timofejev, CEO of Tallinna Vesi, said that the third quarter was characterised by continued progress with planned investments and a commitment to the continuity of the vital service. “Summer is the busiest time of year for water and sewer pipeline construction projects, and our team made the most of it. Four important stormwater receiving systems have been completed or are nearing completion in various districts of Tallinn. This creates the conditions necessary for developing a stormwater network,” he said. Timofejev noted that creating modern stormwater solutions is essential for the functioning...

Continue reading

Good customer activity and strong credit quality led to solid results for the first nine months of 2025 Net profit of DKK 16.7 billion

Press releaseDanske BankBernstorffsgade 40DK-1577 København VTel. + 45 45 14 14 00 31 October 2025 Page 1 of 3Good customer activity and strong credit quality led to solid results for the first nine months of 2025 Net profit of DKK 16.7 billion Carsten Egeriis, Chief Executive Officer, comments on the financial results: “We delivered a solid financial result for the first nine months of 2025 following strong execution on strategic priorities according to our Forward ’28 strategy. Our financial performance was driven by resilient net interest income, continually strong net fee income, effective cost management and low impairments as a result of the strong credit quality of our loan portfolio. Increased customer activity, a growing corporate customer base and market share gains in the corporate segment drove growth in lending and...

Continue reading

Vistin Pharma ASA: Third quarter and YTD 2025 financial results

Vistin Pharma ASA: Third quarter and YTD 2025 financial results Oslo, Norway, 31st of October 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the third quarter of 2025. Revenue in the third quarter ended at MNOK 109 compared to MNOK 106 in Q3 2024. The increase in revenue was driven by 10% higher sales volume. Revenue YTD 2025 ended at MNOK 342 compared to MNOK 316 YTD last year, an increase of 8% Third quarter EBITDA ended at MNOK 28 compared to MNOK 29 in Q3 2024. EBITDA of MNOK 28 positively affected by higher sales volume, offset by lower global metformin prices compared to same quarter last year. EBITDA for first three months of 2025 ended at MNOK 89 compared to MNOK 77 YTD 2024, an increase of 16%. The net profit ended at MNOK 18.5 (16.6) for the third quarter of 2025. All time high production volume in the...

Continue reading

KH Group Plc’s Business Review January–September 2025: Group net sales increased, rescue vehicles integrated into strategy

KH Group Plc Stock Exchange Release 31 October 2025 at 8:00 am EET KH Group Plc’s Business Review January–September 2025: Group net sales increased, rescue vehicles integrated into strategy This is the summary of the Business Review for January–September 2025. The full Business Review is attached to this release and is also available on the company’s website at www.khgroup.com. KH Group July–September 2025 Net sales amounted to EUR 45.3 (39.7) million. Comparable operating profit was EUR 1.2 (1.4) million. Operating profit was EUR 0.9 (1.1) million. Net profit for the period from continuing operations was EUR -0.1 (-0.2) million. Earnings per share from continuing operations were EUR -0.0 (0.0).KH Group January–September 2025 Net sales amounted to EUR 141.3 (132.3) million. Comparable operating profit was EUR 2.2 (3.8) million. Operating...

Continue reading

Quarterly information as at September 30th, 2025

Solid performance over the first nine months 2025 outlook confirmed Strong fundamentals and sustained market demandCergy, October 31st, 2025 Solid 9m 2025 revenue growth, driven by Germany and North-Western Europe  Revenue: €7,518.7m, up +5.4% year-on-year, including +3.6% growth from acquisitions and +2.2% organic growth, of which +5.0% in Germany and + 6.5% in North-Western Europe Sustained market demand, underpinned by our two powerful structural drivers: the energy transition and digital transformation Q3 2025 revenue up +4.7% including +1.8% organic growthHighly positive underlying trends in High Voltage activities, supported by strong order intake and backlog. Following exceptional growth in the first half of the year, projects in Germany and the Netherlands progressed, as planned, at a more measured pace France demonstrated...

Continue reading

48/2025・Trifork Group: Interim report for the three and nine months ending 30 September 2025

Schindellegi, Switzerland – 31 October 2025 Trifork Group AGCompany announcement no. 48/2025Interim Financial Report for the three and nine months ending 30 September 2025Trifork Group reports Q3 revenue growth of 4.7% with a solid margin improvement CEO Jørn Larsen comments:“Q3 was a solid quarter marked by significant contract wins despite a continued challenging private sector business environment. We made further steady progress on our strategy to become a more product- and platform-driven business. Revenue from our own products and operations grew by 25.3% in Q3 and 25.6% in the first nine months, supported by solid momentum in Digital Health and Aviation. The new eight-year and EUR 20 million contract with the Danish Health Data Authority is a testament to our long-standing customer partnerships and our ability to build and operate...

Continue reading

AS Ekspress Grupp: Consolidated unaudited interim report for Q3 and 9 months of 2025

The revenue of Ekspress Grupp continued to grow in the 3rd quarter and the first nine months of the year, driven by the Group’s investments in the fields of conference business, ticket sales and digital outdoor screens. The digital subscriptions of media companies also grew strongly. The revenue of AS Ekspress Grupp for the 3rd quarter of 2025 increased by EUR 1.1 million (+6%) year-over-year, totalling EUR 17.9 million. The revenue for the first nine months of 2025 increased by EUR 3.6 million (+7%) year-over-year to EUR 56.3 million. The top contributors to growth in the 3rd quarter were the business activities of the Estonian Training and Conference Centre (Eesti Koolitus- ja Konverentsikeskus), acquired by Delfi Meedia in July 2024, and the conference company UAB Kenton Baltic, acquired by Delfi Lithuania in December 2024. In...

Continue reading

INTERIM REPORT OF MARIMEKKO CORPORATION, 1 January–30 September 2025: Marimekko’s net sales and operating profit increased in the third quarter

Marimekko Corporation, Interim Report, 31 October 2025 at 8.00 a.m. EET INTERIM REPORT OF MARIMEKKO CORPORATION, 1 January–30 September 2025: Marimekko’s net sales and operating profit increased in the third quarter This release is a summary of Marimekko’s interim report for the January–September period of 2025. The complete report is attached to this release as a pdf file and it is also available on the company’s website at company.marimekko.com under Releases & publications. The third quarter in briefMarimekko’s net sales increased by 8 percent and totaled EUR 50.8 million (47.2). Net sales were boosted in particular by increased wholesale sales both in Finland and internationally. Net sales in Finland grew by 7 percent especially as wholesale sales increased. Increase in Finnish wholesale sales was partly supported by non-recurring...

Continue reading

Third quarter 2025 results: EUR 217 million net income in Q3 2025, contributing to a strong nine-month net income of EUR 642 million

Press release31 October 2025 – N° 18 Third quarter 2025 results                 EUR 217 million net income in Q3 2025, contributing to a strong nine-month net income of EUR 642 millionGroup net income of EUR 217 million in Q3 2025 driven by all business activities (EUR 211 million adjusted1):P&C combined ratio of 80.9% with a low natural catastrophe experience and continued buffer building L&H insurance service result2 of EUR 98 million, with year-to-date experience variance in line with expectations Investments regular income yield of 3.5%, with continued attractive reinvestment ratesIFRS 17 Group Economic Value3 of EUR 8.5 billion as at 30 September 2025, up +12.7%4 at constant economics5 (down -0.9% on a reported basis) compared with 31 December 2024, implying an Economic Value per share of EUR 48 Estimated...

Continue reading

Well-Positioned for Resilient Growth

Key HighlightsDivestment of Jem office is expected to complete by 12 November 2025. Upon completion, approximately S$8.9 million1 gain on disposal will be available for distribution to Unitholders. Retail portfolio achieved positive rental reversion of 8.9%2. Portfolio occupancy improved to 95.0%3,4 driven by active leasing efforts at Building 3 in Milan. Weighted average cost of debt improved to 3.09% p.a. (vs. 3.46% p.a as at 30 June 2025). Inclusion in iEdge Singapore Next 50 Index enhances global visibility and investor recognition. Awarded the Regional Sector Leader (Retail Asia Listed) in GRESB 2025 assessment and maintained 5 Star rating.SINGAPORE, Oct. 30, 2025 (GLOBE NEWSWIRE) — Lendlease Global Commercial Trust Management Pte. Ltd. (the “Manager”), the manager of Lendlease Global Commercial REIT (“Lendlease REIT”),...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.